// App-Quantinova.ai

Mo1740 : OPTICAL ENHANCEMENT AND PROBE CONFOCAL LASER ENDOMICROSCOPY CAN ACCURATELY PREDICT RESPONSE TO BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS

Researchers

Presenter

  • Marietta Iacucci

Principal Investigators

  • Olga Maria Nardone

  • Samuel C. Smith

  • Alina Bazarova

  • Rosanna Cannatelli

  • Uday N. Shivaji

  • Davide Zardo

  • Subrata Ghosh

Medical Centers

  • Department of Surgery, University of Calgary, Calgary, AB, Canada

  • University of Cologne, Cologne, DE, Germany

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre (BRC), Birmingham, UK

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Locations

  • Canada

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Fluorescein sodium

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved